PG
VIVO

Proffitt & Goodson’s Meridian Bioscience Inc VIVO Stock Holding History

Proffitt & Goodson’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-100
Closed -$3.32K – 242
2022
Q4 		$3.32K Hold
100
– – ﹤0.01% 217
2022
Q3 		$3K Hold
100
– – ﹤0.01% 228
2022
Q2 		$3K Hold
100
– – ﹤0.01% 239
2022
Q1 		$3K Buy
+100
New +$2.38K ﹤0.01% 257

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Proffitt & Goodson's VIVO Position: Q1 2023 in Review

Proffitt & Goodson sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 100 shares — an estimated $3.32K sold.

Proffitt & Goodson first reported a position in VIVO in Q1 2022 and held it in 4 quarters. The position peaked at $3.32K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Proffitt & Goodson reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Proffitt & Goodson sold 100 Meridian Bioscience Inc shares in Q1 2023, an estimated $3.32K.
  • Proffitt & Goodson first reported a position in Meridian Bioscience Inc in Q1 2022 and held it in 4 quarters.
  • Proffitt & Goodson's Meridian Bioscience Inc position peaked at $3.32K in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Proffitt & Goodson's 13F filing for Q1 2023, filed 26 Apr 2023.